Pharmafile Logo
Pharmafocus logo
Advanced Search

Steriline’s founder “passes torch” to children with CEO and CSO appointments

September 19, 2024
Corporate, Steriline

Aseptic packaging company Steriline’s founder Gerardo Fumagalli has “passed the torch” to his children Illaria Fumagalli and Federico Fumagalli, who …

Appointment

Butterfly Network Expands its Next-Generation Butterfly iQ3™ to Europe

September 11, 2024
Butterfly Network, medical imaging

Butterfly iQ3 is built on the next-generation Ultrasound-on-Chip™ technology featuring unparalleled image quality, new 3D imaging capabilities, and a smaller, …

News
Press release

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

September 9, 2024
Research and Development Rare Diseases

9 September 2024, –London, UK –Applications for the independently assessed, expert-led Research Grant Initiative, Find For Rare, are open from …

News
Press release

Amferia closes €1,2 million investment to combat resistant bacterial infections

September 3, 2024
Research and Development Amferia, Chalmers Ventures, Dressings, hosiery & appliances, Hospital Management, Immunology, antimicrobial, investment, peptides

Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …

News
Press release
bowel_cancer_screening

The National Institute for Health and Care Excellence announce technology appraisal guidance recommending risankizumab for adult patients with moderate to severe ulcerative colitis

August 29, 2024
Research and Development AbbVie, Crohns, Gastrointestinal tract, Immunology, NICE, approval, ulcerative colitis

The National Institute for Health and Care Excellence (NICE) have recommended adult patients in England or Wales with moderately or …

News

Leadership Appointments at RQM+

August 28, 2024
Research and Development AI and ML, Corporate, RQM+, appointment

Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager On August 27, MedTech service provider RQM+ announced …

Appointment
lungs

European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients

August 27, 2024
Research and Development J&J, Oncology, chemotherapy, non-small cell lung cancer

Today, Janssen-Cilag International, part of Johnson & Johnson (J&J) has announced that the European Comission (EC) has approved a combined …

News

New gastric & gastro-oesophageal junction cancer treatment VYLOY™ ▼ (zolbetuximab): the first claudin 18.2 biomarker targeted therapy licensed in Great Britain

August 16, 2024
GEJ cancers, Gastrointestinal tract, MHRA, Oncology, gastric cancer

Claudin18.2 is an innovative drug-target which is not currently used for any other authorised treatment. There is a large unmet …

News
Press release

First oral treatment for hormone-sensitive prostate cancer recommended by NICE

August 15, 2024
Research and Development Accord healthcare, Oncology, Reproductive health, hormone-sensitive, prostate cancer

Today, Accord Healthcare has announced that the National Institute for Health and Care excellence (NICE) have recommended the first oral …

News

FDA approves drug for primary biliary cholangitis

August 15, 2024
Research and Development FDA Approval, FDA approva;, Hepatology, liver, primary biliary cholangitis

Accelerated approval has been granted for Gilead Science’s Livdelzi (seladelpar) to treat primary biliary cholangitis (PBC) by the US Food …

News

Kerato Ltd Partners with University of Montreal to develop novel treatment for corneal damage

August 14, 2024
Research and Development Kerato, Opthalmology, University of Montreal, corenas

BSF the Main Market listed biotech company and owner of corneal tissue replacement company Kerato Ltd, is pleased to announce …

News
Press release

David Wheadon appointed to board of directors at Seaport Therapeutics

August 14, 2024
Corporate, Seaport Therapeutics, appointment

This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

News

Verisense announce opening of Digital Biobank

August 14, 2024
Research and Development AI, Devices, Diagnostics, Verisense, artificial intelligence, digital health, machine learning

This week, Verisense have announced that their Digital Biobank, with data from over one million people, is open for business.

News

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

August 13, 2024
Clinical Research, Research and Development Ascentage Pharma, Oncology

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …

News
Vaccine image

Pfizer releases results for severe RSV-associated LRTD treatment study

August 13, 2024
Clinical Trial Services, Research and Development Immunology, Pfizer, autoimmune, clinical trial, respiratory, vaccines

US-based Pfizer have announced results from its substudy B of the ongoing phase 3 clinical trial into the safety and …

News
nasal-spray-drawing

First Nasal Spray for Treatment of Anaphylaxis approved by FDA

August 12, 2024
Research and Development Emergency Medicine, FDA, anaphylaxis, epinephrine, nasal

ARS Pharmaceuticals has been granted approval by the US Food and Drug Administration (FDA) for their epinephrine nasal spray, neffy, …

News
acute_leukemia-all

Merck to acquire Curon Biopharmaceutical’s B-Cell Depletion Therapy

August 12, 2024
Research and Development Corporate, Curon Biopharmaceuticals, Merck, Oncology, b-cells

Merck have announced that they have entered into an agreement with private biotechnology company Curon Biopharmaceuticals to acquire CN201, a …

News

Richmond promotes new Director of Communications and Participant Engagement

August 9, 2024
Research and Development Corporate, Richmond Pharmacology, appointment, pharmaceutical

Richmond Pharmacology is delighted to announce the promotion of Liz Romano to the new position of Director of Communications and …

Appointment

Janssen’s study for nipocalimab as indicated for EOS-HDFN published in The New England Journal of Medicine

August 9, 2024
Research and Development Haematology, Janssen, New England Journal of Medicine, Obstetrics & Gynaecology, foetus, newborn, women's health

Johnson & Johnson company Janssen has announced that the results from its phase 2 trial into nipocalimab have been published …

News

Cresset collaborates with global leaders Enamine to enable the design of new Targeted Protein Degraders 

August 9, 2024
Research and Development Corporate, Cresset, Cressete, Enamine, Microbiology, Targeted Protein Degraders

This week, drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026